The predictive role of modified TIMI risk index in patients with ST-segment elevation myocardial infarction

dc.contributor.authorKaya, Adnan
dc.contributor.authorKeskin, Muhammed
dc.contributor.authorGüvenç, Tolga Sinan
dc.contributor.authorTatlısu, Mustafa Adem
dc.contributor.authorKayapınar, Osman
dc.date.accessioned2020-04-30T23:34:02Z
dc.date.available2020-04-30T23:34:02Z
dc.date.issued2019
dc.departmentDÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.descriptionGuvenc, Tolga Sinan/0000-0002-6738-266X; Keskin, Muhammed/0000-0002-4938-0097en_US
dc.descriptionWOS: 000459619200005en_US
dc.descriptionPubMed: 29475415en_US
dc.description.abstractBackground: The prognostic value of thrombolysis in myocardial infarction (TIMI) risk index (TRI) has been reported in patients with coronary artery disease. In this study, we evaluated the additional prognostic value of blood urea nitrogen (BUN) level to the TRI in patients with ST-segment elevation myocardial infarction (STEMI). Methods: We evaluated the in-hospital and long-term (3-year) prognostic value of modified TRI (mTRI) in patients with STEMI. The mTRI is calculated using the following equation; mTRI = (TRI x BUN)/10. Patients were stratified into 5 groups according to 20-point increments of mTRI. Results: The patients with higher mTRI had significantly higher in-hospital and long-term mortality. The risk for in-hospital and long-term mortality was highest for those within the Q5 (36.8 and 42.3%, respectively) and it was significantly higher than all the other groups (p < .001 for both). Conclusions: In this study, the prognostic value of TRI has been augmented by multiplication of TRI with BUN/10. Therefore, we present a pilot study of association of mTRI with overall STEMI patients.en_US
dc.identifier.doi10.1080/00015385.2018.1439704en_US
dc.identifier.endpage36en_US
dc.identifier.issn0001-5385
dc.identifier.issn1784-973X
dc.identifier.issue1en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage29en_US
dc.identifier.urihttps://doi.org/10.1080/00015385.2018.1439704
dc.identifier.urihttps://hdl.handle.net/20.500.12684/5092
dc.identifier.volume74en_US
dc.identifier.wosWOS:000459619200005en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofActa Cardiologicaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectST-elevation myocardial infarctionen_US
dc.subjectprimary percutaneous interventionen_US
dc.subjectmortalityen_US
dc.subjectrisk assessmenten_US
dc.titleThe predictive role of modified TIMI risk index in patients with ST-segment elevation myocardial infarctionen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
5092.pdf
Boyut:
731.37 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text